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20 Government Efforts to Aid 
Consumer Well-Being 
Understanding Federal Health Warnings and Disclosures 
Jeremy Kees, Scot Burton, and J. Craig Andrews 
Many products marketed in the United States and around the world can cause 
harm to consumers if misused. Of even greater concern, some products, such as 
combustible tobacco, can be inherently harmful to consumers even when used 
as intended (CDC, 2014a). Since the emergence of the modern-day Federal 
Trade Commission (FTC) and Food and Drug Administration (FDA) in the 
1930s, the U.S. government has enacted legislation and regulations that help 
to protect consumers through information disclosures and/or warnings to 
identify potential risks. Laws and regulations involving consumer protection 
are directly related to the provision of objective and truthful information 
to consumers and how they, in turn, utilize this information. These laws 
are designed to prevent organizations from engaging in deceptive or unfair 
business practices and to help protect the rights of consumers. For example, 
in the United States, agencies such as the FDA, FTC, Consumer Product 
Safety Commission (CPSC), Federal Communications Commission (FCC), 
and others establish and enforce regulations that help to protect consumers. 
As part of this regulation, agencies often require marketers to provide disclos-
ures or warnings on packaging or at the point of purchase, particularly for 
products in which safety or public health is an issue, such as for food, tobacco, 
and prescription drugs. 
Federal agencies make decisions regarding whether or not a warning or 
disclosure is appropriate and how such information should be presented 
to consumers. To make these decisions, agencies require a clear understanding 
of how consumers acquire, process, and use warning and/or disclosure infor-
mation. Furthermore, federal agencies take into account consumers' initial 
beliefs and knowledge regarding the product, potential individual differences 
among consumers, economic costs and benefits, and situational moderators. 
At any point in time, agencies may be deluged with hundreds of current or 
emerging questions that present opportunities for consumer research. However, 
due to time and resource constraints, existing regulations and court decisions, 
and filing requirements for new regulations (e.g., Office of Management 
and Budget; Federal Register posting), the federal agencies are only able to 
address a small fraction of these questions and issues that often have important 
implications for consumer health and well-being. This situation therefore 
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creates both an important need and rich opportunity for consumer researchers. 
In this chapter, we first introduce conceptual frameworks for the study of 
warnings and disclosures. We also review recent research on critical topical 
domains. We also highlight areas that offer substantial opportunity and need 
for additional study. 1 
Several well-established information processing models can serve 
as useful guides for government agencies making decisions about the design 
of warnings and disclosures and the evaluation of intended and unintended 
outcomes for consumers and marketers. For instance, the Transtheoretical 
Model (i.e., "Stages of Change") (cf. Prochaska & DiClemente, 1983) measures 
one's progression through precontemplation, contemplation, preparation, 
action, maintenance, and possible relapse stages as a result of interventions to 
reduce product addictions (e.g., to nicotine, alcohol, prescription drugs, and 
other drugs). Similarly, Protection Motivation Theory (cf. Rogers, 1975) posits 
that we respond to interventions to change our behavior based on the perceived 
severity of a threatening event, the perceived probability of the occurrence 
(vulnerability), the efficacy of the recommended preventive behavior to reduce 
our risk, and our perceived ability to undertake the recommended preventive 
behavior (self-efficacy). These models have been useful in understanding 
situations in which the warning or disclosure presents an impending threat as 
part of the counterpersuasion process. However, sometimes warnings and 
disclosures can be beneficial even when they do not present an explicit 
impending threat directly to consumers. Thus, a broader model of consumer 
information processing may be more appropriate for the study of disclosures 
and warnings. 
Perhaps the most broadly applicable framework to the study of warnings 
and disclosures is McGuire's Steps in Information Processing (1980). In this 
model, McGuire offers a helpful set of output variables into which effects on 
warnings and disclosures can be categorized: exposure, perception (attention), 
comprehension, agreement (attitude change), retention, retrieval, decision 
making (intentions), and action (behavior). These outcomes are specified by 
McGuire (1980) in his Communication-Persuasion Matrix and also include the 
following input variables: source, message, channel, receiver, and destination. 
More recently, the "Logic Model" (cf. Burke, 2007) has applied aspects of 
communication variables as inputs and information processing steps as outputs 
I Interested readers are referred to earlier and more detailed reviews of general warnings and 
disclosures research (cf. Andrews, 2011; Argo & Main, 2004; Bettman, Payne, & Staelin, 1986; 
Cox, Wogalter, Stokes, & Murff, 1997; Morris, Mazis, & Barofsky, 1980; Stewart & Martin, 
1994), as our focus is on the application of federal agency health warnings and disclosures to the 
most current public policy issues. 
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and outcomes in planning and evaluation activities by federal and funding 
agencies. A similar, yet more succinct, model is Wogalter's (2006) 
Communication-Human Information Processing (C-HIP) Model. This is a 
helpful, alternative framework for considering public policy issues involving 
warnings and disclosures and for understanding their effects. 
Based on these theoretical frameworks, we present a "Model of Consumer 
Responses to Warnings and Disclosures" in Figure 20.1 that identifies 
important outcome variables to consider when designing warning and disclos-
ure programs. These include receiver outcome variables that are based on 
prior information processing and persuasion frameworks (e.g., Burke, 2007; 
McGuire, 1980; Petty & Cacioppo, 1986; Rogers, 1975; Wogalter, 2006). 
In addition, we identify specific individual and situational variables (e.g., prior 
expectations, complexity of choice, experience with the product, shopping 
environment) that have proven to be important in the disclosure and warning 
literature. Given this conceptual lens, we now examine graphic tobacco warn-
ings, nutrition disclosures, and other federal agency applications of warnings 
and disclosures utilizing aspects of our model. 
SOURCE 
Consumers may respond differently depending on if the disclosure is 
from the government (e.g., NFP, Cigarette W/lffiing) versus marketer 
(e.g., facts Up Front, Harm Reduction Claim) 
ATTENTION I ACQUlSTION 
Depending on where/how the disclosure/warning is displayed on the 
package, consumers may attend to it less (NFP on back) or more 
(FOP; graphic warnings) 
COGNITIVE AND/OR EMOTIONAL RESPONSES 
The warning/disclosure may generate an emotional response andlor 
a cognitive response, which may dictate how they cope with the 
warning or disclosure message. 
PROCESSING I COMPREHENSION I INTEGRATION 
Consumers use disclosure/wllflling infonnation to fonnulate a 
personal risk analysis and decide now to behave. 
BEHAVIOR (CONSUMER) 
Consumers fommlate evaluations/judgments based on 
warning/disclosure and take actionJnon-action 
BEHA\10R (MARKETER) 
Based on required disclosure/waming1 the marketer may refonnulate 




Consumer Segments (adolescent smokers, high 
nutrition motivation); knowledge/experience with 
tlle product; literacy; prior expectations; self-
control 
SITUATIONAL I CONTEXTUAL VARIABLES 
Complexity of the choice; competing package 
infonnation (brand, other claims); time constraints; 
shopping environment 
GOALS 
Promotion vs. Prevention Focus 
Smoking (social vs. addiction) 
food (nutrition vs. value) 
Figure 20.1 A Model of Consumer Responses to Warnings and Disclosures. 
Note: The model is adapted from the following information processing and persuasion 
models: Logic model (Burke, 2007); Communication-Persuasion Model (McGuire, 
1980); Protection Motivation Theory (Rogers, 1975); Elaboration Likelihood Model 
(Petty & Cacioppo, 1986); and the Communication-Human Information Processing 
(C-HIP) Model (Wogalter, 2006 ). The moderators identified represent a subset of the 
broad array of possible conceptual and practical moderators researchers may examine. 
l 
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In the twentieth century, 100 million people died worldwide from 
tobacco-related diseases, and approximately 8 million deaths due to tobacco 
use are expected annually by 2030 (CDC, 2014a; Jha, 2009). In the United 
States, it has been fifty years since the first Surgeon General report on the health 
effects of smoking. Shortly after, in 1965, Congress passed the Federal Cigarette 
Labeling and Advertising Act (FCLAA), which required health warnings on all 
cigarette packages. Despite five decades of government regulation designed to 
warn consumers about the dangers of tobacco use, tobacco remains the leading 
cause of preventable disease and death in the United States, resulting in more 
than 480,000 deaths per year (DHHS, 2014). Along with antitobacco media 
campaigns, taxation, and restrictions on tobacco marketing, on-package 
warnings are an important mechanism to help curb tobacco use. Given the 
worldwide push for stronger and more graphic cigarette warning labels, and the 
rapidly changing regulatory environment for alternative tobacco products, 
tobacco is an important and fruitful area to study disclosures and warnings. 
This section begins with a discussion of the most dangerous form of tobacco, 
combustible cigarettes, and the role that warnings play in discouraging cigarette 
smoking. Next, we will address alternative tobacco products (i.e., electronic 
cigarettes) and the role that disclosures and warnings play for these potentially 
"modified risk" tobacco products. Research needs are identified, and given the 
rapidly changing (and controversial) regulatory environment for tobacco, there 
are excellent opportunities to contribute to this very important area of study. 
Cigarettes and Graphic Health Warnings 
In 2009, Congress passed the Family Smoking Prevention and Tobacco Control 
Act (FSPTCA), which put tobacco legislation under the FDA's purview for the 
first time in American history (FSPTCA, 2009). The law also mandated the 
use of larger, more prominent graphic health warnings (GHWs) on cigarette 
packages. This law would have marked the first change in cigarette warnings in 
the United States since warnings were first required on cigarette packages 
in 1965 by the FCLAA. However, in 2012, a federal appellate court affirmed 
a lower court's decision to strike down the proposed rule. The court ruled 
that the new graphic warnings proposed by the FDA violated corporate free 
speech rights and that the FDA had failed to provide "a shred of evidence" that 
the new graphic warnings would reduce smoking rates. Yet, others have coun-
tered this assertion based on the existing research evidence on GHWs (Myers, 
2013). While graphic cigarette warnings have been put "on hold" in the United 
States, some fifty-eight countries worldwide, covering about one-third of the 
world's population, have adopted graphic warnings since Canada became 
the first country to require them in 2000 (Hammond et al., 2004; World Health 
Organization, 2014). Some examples of these graphic health warnings are 
shown in Figure 20.2. 
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Figure 20.2 Examples of Graphic Health Warnings. 
To date, there has been considerable research on the effects of GHWs 
(cf. Myers, 2013) that address a wide variety of outcomes in our model 
(see Figure 20.1). For example, in one of the first studies conducted after GHWs 
were required in Canada, Hammond and colleagues (2004) found that almost 
all Canadian smokers (91 percent) had read the warning labels and demon-
strated a thorough knowledge of their content. A strong positive relationship 
was then observed between a measure of cognitive processing and smokers' 
intentions to quit and later cessation behavior. Eye-tracking studies have 
shown positive effects on viewing of the graphic warning text and dwell time 
in cigarette ads (Strasser et al., 2012). Other GHW eye-tracking research shows 
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greater attention toward health warnings compared to brand information when 
shown on plain packs (i.e., without the colored logo associated with the brand 
name) versus regular branded packs, with effects observed among nonsmokers 
and weekly smokers, but not daily smokers (Munafo, Roberts, Bauld, & 
Leonards, 2011). Yet, interestingly, Maynard and colleagues (2014) found in 
an eye-tracking study that regular smokers fixated more on the branding rather 
than the health warning. This bias was smaller, but still evident, for "blank 
packs," where smokers preferentially attended to the blank region over the 
health warnings. 
Other GHW research has examined further processing of the warnings 
beyond attention in experimental (causal) research. For example, using adult 
smokers from the United States and Canada, Kees, Burton, Andrews, and 
Kozup (2006) show that the addition of the GHW to the text-based warning 
significantly decreases the perceived attractiveness of the cigarette package. 
Similarly, Peters and colleagues (2007) find that the Canadian labels (combined 
text and GHWs) produced a greater negative response for U.S. adult smokers 
than the U.S. text warnings, without any signs of defensive or reactive 
responses. Later, Kees, Andrews, and Kozup (2010) discovered that the more 
graphic the warning, the greater the evoked fear, and fear acts as a mediator 
that explains increases in quit intentions for adult smokers. Romer, Peters, 
Strasser, and Langleben (2013) note that smoker self-efficacy in quitting is 
important in gauging the effects of the GHWs, as. self-efficacy is lowest for 
new smokers and long-time smokers. Thus, they find that the GHWs are most 
effective for smokers with stronger quit-efficacy beliefs. 
Additional research has shown that GHWs can lower intentions to smoke 
among young adult, occasional smokers (Blanton, Snyder, Strauts, & Larson, 
2014), significantly reduce craving and electrophysiological brain responses to 
smoking cues (Wang et al., 2013), and influence affective and cognitive responses 
for adult smokers (Emery et al., 2013), as \Veil as for young adult smokers and 
susceptible youth (Nonnemaker et al., 2010). Yet, given that 88 percent of 
current smokers begin during adolescence, an important population for the study 
of the GHWs is adolescent smokers (Kessler et al., 1997; Surgeon General 
Report, 2012). In a study of dual pathways to persuasion, Andrews, Netemeyer, 
Kees, and Burton (2014) find that both emotional responses (evoked fear) and 
beliefs from the GHWs affected adolescent smokers' thoughts of quitting. 
Evoked fear is found to have a stronger effect than beliefs in mediating the effects 
of GHWs on quit thoughts for adolescent smokers, yet this is reversed in a 
longitudinal study of young adult smokers. A recent examination of male, 
adolescent nonsmoker data (Pepper et al., 2013) reveals that the GHWs discour-
aged most male adolescents from wanting to smoke, but lung cancer warnings 
discouraged them more than addiction warnings. Finally, moderators can have 
an important impact on the effectiveness of the GHWs. For example, Andrews 
and colleagues (2014) show that smoking frequency for both adolescents and 
young adults moderated the impact of the GHW levels on quitting thoughts. In 
Zhao, Nan, Yang, and lies (2014), warning message framing is an important 
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moderator, with a loss frame found to be more effective than a gain frame. For 
text-only GHWs, message framing did not matter. Thus, in sum, as argued by 
Myers (2013), there is clear evidence across the stages of information processing 
indicating that the GHWs are effective. 
Challenges in Developing Cigarette Warnings and Directions 
for Future Research 
As noted previously, a specific challenge to developing effective cigarette 
warnings is the dearth of research examining the most important target audi-
ence for these types of warnings: adolescents. As noted previously, tobacco use 
is almost always initiated during adolescence. Each day, 3,200 adolescents 
under age eighteen smoke their first cigarette, and one-fifth of these youths 
become daily smokers (DHHS, 2014). From a persuasion standpoint, it is 
problematic that most of the 10 million adolescents in the United States who 
are open to trying smoking, or have already tried smoking, do not consider 
themselves smokers (FDA, 2014c). This segment also may not be particularly 
interested in the topic of tobacco risks and may not believe they will become 
personally addicted to tobacco (Arnett, 2000; Mayhew, Flay, & Mott, 2000). 
Thus, it is particularly challenging to develop warning messages to reach an 
audience who is not interested in the topic and likely does not feel like the 
message is relevant to them. Given these significant challenges, research is 
needed to understand how warnings can best reach this critical segment. 
Consistent with the model of consumer responses to warnings and disclosures 
offered in Figure 20.1, the following questions are important to consider: Can 
cigarette warnings be designed to capture adolescents' attention? What types of 
warning will adolescents notice and comprehend? Is this segment more prone to 
a cognitive/factual appeal or can an emotional message be more effective? In 
one of the few studies examining the impact of graphic cigarette warnings on 
adolescent smokers, Andrews and colleagues (2014) find that highly graphic 
warnings were effective at impacting adolescent smokers' thoughts of quitting. 
Clearly, studies increasing our understanding of the breadth of adolescents' 
emotional and cognitive reactions to GHW's and plain packaging are needed. 
More generally, research addressing how cigarette warnings impact adolescent 
smokers and nonsmokers' beliefs about smoking and smoking behavior will be 
beneficial to policy makers and the public health community. 
Time is also an important issue in considering the effects of labeling. The vast 
majority of studies that examine cigarette warning labels are cross-sectional in 
nature. These studies typically examine the impact of different types of warn-
ings on short-term response outcome variables such as attitude, beliefs, affect, 
and intentions. While results from these studies are useful, some scholars note 
the potential for the warnings to become less effective or "wear out" after 
repeated exposure (Strahan et al., 2002). It is especially important from a 
regulatory perspective to understand what types of warnings have an effect that 
persists over time. While there have been studies that have examined the impact 
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of antismoking media campaigns over time (e.g., Siegel & Biener, 2000), there 
have been very few studies that have studied the impact of warnings using a 
longitudinal design (Hammond et al., 2004). In one study that examines 
the impact of different graphic warning labels, Andrews and colleagues (2014) 
find that graphic warnings can have a carryover effect on thoughts of quitting 
smoking for young adult smokers after a one-week delay following exposure to 
the cigarette package warning. Currently, the FDA is conducting longitudinal 
research to measure the impact and effectiveness of "The Real Cost" antismok-
ing campaign in which they will follow thousands of the same youths over a 
two-year period in seventy-five major media markets, assessing potential 
changes in their smoking behavior over time (FDA, 2014d). More longitudinal 
research is needed to understand the impact of cigarette warning labels on 
smoking behavior over time (see Figure 20.1) and the moderators impacting 
these effects. 
Finally, there have been very few studies that can directly attribute cessation 
behaviors to cigarette warnings. Due to methodological challenges (e.g., inter-
vening variables that are difficult to control), coupled with the nature of the 
regulated environment, the ability to demonstrate that any cigarette warning 
directly results in smoking cessation can be challenging. For a highly addictive 
behavior such as smoking, while some warnings may be able to encourage 
attempts to quit or the reduction of smoking frequency; they are unlikely to 
be the sole reason for cessation. Any research that can demonstrate a causal 
relationship between a warning and actual smoking behavior and demonstrate 
that the warning can singularly reduce smoking incidence (while controlling 
for other influential factors and possible intervening variables) would make an 
important contribution to the warnings literature. In the absence of research 
with smoking incidence as the outcome variable, studies could employ depend-
ent variables, such as number of cigarettes smoked over time, calls to a quit 
line, and purchase of medications to assist with cessation. 
Clearly, combustible tobacco products (e.g., cigarettes, cigars, cigarillos, 
hookah in which tobacco is burned and inhaled) are the most dangerous form 
of tobacco and pose the greatest risk to consumer health and well-being. It is 
in the best interest of public health to persuade smokers to quit. However, given 
the challenges associated with getting smokers to quit smoking altogether, there 
has been considerable debate within the public health community around the 
potential benefits of encouraging cigarette smokers to switch to a "less harmful" 
form of tobacco (Haar, 2014). If there is some health benefit to consumers 
switching from combustible cigarettes to an alternate form of tobacco, how 
might warnings and disclosures inform consumers of this benefit while still 
generally discouraging tobacco use, especially for potential new users? Can 
warnings and disclosures be designed both to persuade smokers to quit using 
tobacco and, in the absence of quitting, at least use a less dangerous form? Can 
disclosures on alternative tobacco products communicate the realistic (lower) 
risks of the product relative to combustible cigarettes, without the unintended 
consequences of attracting new or former tobacco users, contributing to 
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adolescent nicotine use, or encouraging poly-use of tobacco products 
(Bombard, Pederson, Nelson, & Malarcher, 2007)? These are some of the issues 
we address in the next section. 
New Frontiers: Modified Risk Tobacco Products 
No tobacco product is safe. However, some forms of tobacco may be more 
dangerous to consumers' well-being than others. This is the premise for the 
provision under the Family Smoking Prevention and Tobacco Control Act 
(2009) that could potentially allow some modified risk tobacco products 
(MR TPs) to be marketed as "less harmful" or to "reduce the risk of tobacco-
related disease" pending an MRTP application to the FDA's Center for 
Tobacco Products (FSPTCA, 2009). Examples of potential MRTPs include 
tobacco lozenges and e-cigarettes; the latter has grown from $2 million in sales 
in 2009 to $722 million in 2013 (Wall Street Journal, 2014). Any modified-risk 
claims would have to be backed by scientific evidence and would need to 
benefit the health of the population as a whole, taking into account both users 
and non-users of tobacco products. Gaining approval from the FDA to sell an 
MR TP would not signal that the product itself is safe or improves the health 
of the consumer. This designation would simply imply that the product has 
the potential to reduce tobacco-related harms compared with conventional 
tobacco products (i.e., combustible cigarettes). Furthermore, any potential 
MR TP must also contribute to reducing the overall rates of tobacco use and 
tobacco-related harm across the country. 
There is a dearth of research regarding the actual and perceived health 
effects of MR TPs to guide federal regulatory decisions (10M, 2011 ). In one of 
the few studies that examines the potential impact of tobacco harm reduction 
statements, Capella, Taylor, and Kees (2012) find that a disclosure suggesting that 
smokeless tobacco is less risky than cigarettes did not significantly impact con-
sumers' relative risk perceptions of smokeless tobacco. The authors suggest that 
this lack of effect may be due to the presence of the mandated warning label 
that was present on the experimental stimuli or the lack of perceived credibility 
of the harm reduction statement, which was not attributed to the FDA in the 
studies. Thus, there is need for more research that examines how consumers may 
process any "harm reduction" disclosures for MR TPs, especially for absolute 
levels of safety and risk. Even if the evidence suggests that a modified risk tobacco 
product is safer than conventional tobacco products, will consumers interpret 
this information as suggesting that the product is objectively "safe" when it clearly 
is not? After all, such absolute health halos have occurred in the processing 
of relative nutrient content claims (cf. Andrews, Burton, & Netemeyer, 2000). 
Thus, it is unclear how the potential labeling of some tobacco products as less 
risky will impact consumers. These are the types of research questions that should 
be considered for various emerging alternative tobacco products. 
The FDA is committed to "stopping practices that may cause people to start 
or continue using tobacco products that could lead to preventable disease 
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and death," but at the same time the FDA's goal is to "reduce the number of 
tobacco-related deaths" (FDA 2012). While these two goals may seem aligned, 
an important question to be considered is whether or not the communication 
of MR TPs as less risky could result in a "net positive" effect of fewer total 
tobacco-related diseases and deaths. Could the number of smokers who switch 
exclusively to a less dangerous alternate tobacco product offset the number 
of potential new tobacco users who start using the MR TPs? Recent research 
shows that approximately 32.1 percent of adults in the United States use one or 
more tobacco product (with 18 percent smoking cigarettes), and 10.6 percent 
of adults are multi-users ("poly-users") of tobacco in the United States, includ-
ing cigarettes, cigars, little cigars, electronic cigarettes, hookahs, smokeless 
tobacco, and snus (Lee, Hebert, Nonnemaker, & Kim, 2014). Given this usage 
pattern, the communication of benefits and risks to consumers by way of 
disclosures and warnings is an important topic in need of additional research. 
Electronic Cigarettes 
Perhaps the most popular tobacco product that has been promoted as 
having potential for harm reduction is electronic nicotine delivery systems 
(i.e., electronic cigarettes, or e-cigarettes) (Etter et al., 2011). These products 
tend to have a physical form that somewhat resembles a traditional cigarette, 
but they use electrical heating elements to vaporize a glycerol solution contain-
ing nicotine, which is inhaled by the user. E-cigarettes are aggressively marketed 
in the United States, and as a result consumer use of the products is increasing 
rapidly (Chen, 2013). In fact, youth exposure to television e-cigarette ads 
measured by target rating points (TRPs) increased 256 percent from 2011 to 
2013 (Duke et al., 2014). Additionally, in a recent Congressional Report (2014), 
e-cigarette companies were cited for promoting their products at youth-oriented 
events and offering their e-cigarettes in flavors appealing to adolescents 
(e.g., Cherry Crush, Chocolate Treat). 
While the FDA currently only regulates e-cigarettes that are marketed for 
therapeutic purposes, a proposed rule extends (or "deems") the agency's 
tobacco authority to cover e-cigarettes (FDA, 2014a). This proposed rule would 
prompt the FDA to implement regulatory tools such as age restrictions for 
minors and manufacturing standards. Importantly, the FDA also would regu-
late any modified risk claims that may suggest e-cigarettes can reduce tobacco-
related disease and death, and any warnings that indicate that e-cigarettes are 
no less addicting than traditional tobacco. This is important, as e-cigarettes are 
commonly marketed as safer alternatives to combustible cigarettes and even as 
smoking cessation aids. U.S. sales of e-cigarettes have increased to $1.7 billion 
from almost nothing in a five-year period, and some estimate the market 
could expand to $10 billion in the next three years (Duprey, 2014). Given that 
e-cigarettes are an extremely high-growth tobacco product in the United 
States, much research (in both the social and hard sciences) is needed to 
understand the specific risks and how to communicate these risks to consumers. 
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At present, research is mixed in regards to the efficacy of e-cigarette in 
helping smokers quit. Siegel, Tanwar, and Wood (2011) conducted a study using 
216 smokers who had purchased e-cigarettes for the first time. Results showed 
that 31 percent of the sample reported cigarette smoking abstinence after six 
months, and, of those who were not smoking, 34 percent reported being nicotine-
free. Almost two-thirds of the sample reported a reduction in the number of 
cigarettes they smoked. In contrast, Bullen and colleagues (2013) found that 
of the 289 smokers who tried e-cigarettes as a means by which to quit smoking, 
only 7 percent had quit smoking after six months. Finally, after reviewing 
the existing clinical trials involving e-cigarettes as a cessation strategy, Grana, 
Benowitz, and Glantz (2014) concluded that e-cigarettes are not associated with 
successful cessation in general population-based samples of smokers. Regardless 
of whether or not e-cigarettes are, in fact, an effective method to quit smoking, 
smokers seem to perceive them as such. In fact, the majority of e-cigarette users 
report smoking reduction or cessation as their primary motivation for using 
the product (Goniewicz, Lingus, & Hajek, 2013). In a recent survey of over 
1 ,500 smokers, those who tried e-cigarettes as a means by which to quit smoking 
reported a higher motivation to quit, higher quitting self-efficacy, and longer 
recent quit duration than did other smokers (Pokhrel et al., 2013). 
One critical issue that is fruitful for future research is whether and how 
e-cigarettes can be marketed as a modified risk tobacco product or as a smoking 
cessation tool. Research in the New England Journal of Medicine suggests that 
e-cigarettes are likely to contain lower levels of toxins and carcinogens than 
combustible cigarettes (Cobb & Abrams, 2011). Yet, another well-controlled 
study of samples from twelve brands of e-cigarettes indicates that although 
levels of toxicants were 9 to 450 times lower than those of cigarette smoke, 
they still contained significantly higher levels of many carcinogenic and toxic 
compounds (e.g., formaldehyde, acetaldehyde, nitrosamines, cadmium, nickel, 
and lead) compared with Nicorette inhaler vapor (Goniewicz et al., 2013). 
Currently, U.S. tobacco marketers are not required to disclose the ingredients 
in their e-cigarette products, which have been found to deliver inconsistent 
levels of nicotine and contain some toxins (Riker, Lee, Darville, & Hahn, 
2012). However, when the FDA implements regulations related to manufactur-
ing standards for e-cigarettes, it should be possible to discern the level of risk 
of e-cigarettes relative to combustible cigarettes. Even given the uncertain 
science around the risks of e-cigarettes, from a public health perspective, it 
appears that society would in theory be better off if tobacco consumers used 
only e-cigarettes rather than combustible cigarettes (American Cancer Society, 
2014). Of course, the potential for poly-use, nicotine poisoning among young 
children, and new and former tobacco users entering the market complicates the 
issue. Recently, a Centers for Disease Control and Prevention (CDC) study 
showed the percentage of e-cigarette users in high school more than doubled 
from 4. 7 percent to 10 percent from 2011 to 2012, and more than 20 percent 
of middle-school students who reported using e-cigarettes claimed that they 
never had even tried traditional cigarettes (CDC, 2013). 
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It is unclear what (if any) messaging can be developed that would be effective 
at communicating the lower risk of e-cigarettes without the unintended conse-
quence of attracting new tobacco users to the product as "dual-use" tobacco 
users, which would obviously be undesirable for public health. Recent research 
has confirmed that attracting new, young, tobacco users is a legitimate concern. 
Using data from the National Youth Tobacco Survey, Dutra and Glantz (2014) 
concluded that middle and high school students who use e-cigarettes are more 
likely to become regular smokers of combustible cigarettes. Other studies have 
found that e-cigarettes are perceived positively by young adults, and this 
segment is willing to experiment with the product (Choi et al., 2012). 
Currently, e-cigarettes are not required to carry any warnings on packaging 
or advertising. As the FDA begins to create policy for e-cigarettes, research 
will be needed to guide these regulatory decisions. Should e-cigarettes carry the 
same Surgeon General warnings as more conventional tobacco products? 
While combustible cigarettes appear to warrant the strongest types of warnings 
about the health risks of smoking, will these types of warnings be appropriate 
fore-cigarettes, where the long-term health risks are not yet fully understood? 
While nicotine use should be discouraged, mandatory disclosures and warnings 
ought to be truthful, objective, and reflect what the scientific evidence tells us 
about the product risks. Research is needed to understand how consumers may 
respond to mild or ambiguous warnings about the uncertain long-term risks of 
e-cigarettes, as well as perceptions of health risks (beyond addiction) associated 
with combustible products. 
Alternatively, given prior consumer testing withe-smokers ("vapers"), would 
a disclosure approach similar to qualified health claims on food products 
be more appropriate? In this scenario, the e-cigarette marketer would be 
allowed to claim that e-cigarettes are a safer form of nicotine consumption than 
combustible cigarettes, but would also be required to disclose that nicotine 
is highly addictive and that the long-term risks associated with the product 
are not understood. Of course, the critical research questions for any warning 
or disclosure approach would concern how young consumers, and other 
non-tobacco smokers considering trial, interpret the information. Will mild 
warnings or harm reduction claims (with risk disclosures) result in increased 
e-cigarette initiation rates and "duel use" of e-cigarettes and conventional 
tobacco products? In essence, is it possible to make truthful claims about 
the benefits of MRTPs (relative to conventional tobacco products) without 
experiencing the unintended consequence of drawing in new tobacco users? 
Finally, research would be needed to determine which segments may be most 
receptive to modified risk tobacco disclosures. 
In the past fifty years, the prevalence of obesity among U.S. adults 
almost tripled, growing from approximately 13 to 36 percent (NIH, 2014). 
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Obesity is directly or indirectly related to chronic health conditions and diseases 
such as cancer, diabetes, and heart disease and is associated with some three 
hundred thousand deaths annually after adjustments for age and smoking 
factors (CDC, 2014b; U.S. Surgeon General, 2013). With more than two-thirds 
of Americans aged twenty years or older who are now overweight, there are dire 
concerns about the future impact on long-term consumer welfare. Estimates 
of the annual financial cost of obesity in the United States reach as high 
as $200 billion, which include direct medical costs, lost productivity costs, 
transportation costs, and human capital costs (Hammond & Levine, 2010). 
Thus, U.S. agencies such as the FDA and USDA are concerned about the 
immediate and long-term consequences of obesity, which clearly represents 
a critical health issue to the well-being of many consumers. How nutrition 
information (e.g., calories, levels of saturated fat and sodium) is communicated 
and used by consumers in evaluations and decisions has become an increasingly 
crucial issue. Federal agencies such as the FDA should apply an appropriate 
conceptual lens as the agency considers the complex manner in which nutrition 
information is communicated, interpreted, and utilized by consumers. This 
includes information communicated through the two major sources of where 
and how consumers obtain their food: (1) nutrition disclosures relevant 
to purchases made at the retail stores and then subsequently prepared and 
consumed in the home, and (2) purchases of prepared foods from restaurants 
or other locations away from home. 
y.s. consumers have had access to specific and thorough standardized 
nutrition information in the Nutrition Facts label found on the back or side 
of food packages since 1993. The disclosure of this information was mandated 
by the Nutritional Labeling and Education Act (NLEA) of 1990, and the 
FDA conducted qualitative and quantitative research to aid in the design 
of the Nutrition Facts disclosure. A primary objective of the NLEA was to 
help consumers make "more informed and healthier food choices in the context 
of their daily diet" (NLEA, 1990; Federal Register, 201 Oa ). 
However, as noted previously, since the time the standardized Nutrition 
Facts label was added to packages, we have seen concomitant increases in 
obesity rates among U.S. consumers. Thus, many would dispute whether 
the provision of information through FDA regulation has been effective in 
communicating the information to aid consumers in making food choices and 
whether it is capable of changing consumers' dietary habits (Heike & Taylor, 
2012). Others note that not all consumers consult the label when making 
purchases (Choiniere & Lando, 2013), and that perhaps the obesity crisis would 
have been even more severe without standardized labeling (Andrews, Lin, Levy, 
and Lo, 2014). The model offered in Figure 20.1 includes the most significant 
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issues related to how nutrition information disclosures are presented and subse-
quently processed by consumers in retail environments. 
U.S. consumers have increasingly busy lifestyles, and at the retail shelf, 
nutrition and health-related evaluations and choices can be daunting. Despite 
the presence of the Nutrition Facts disclosure, one recent survey reported that 
many consumers still believe it is harder to identify healthier products while 
shopping at their grocery retailer than to do their own taxes (IFIC, 2012; 
Newman, Howlett, & Burton, 2014). This difficulty is impacted not only by 
the thousands of product alternatives crowding the retail shelf, but the fact 
that the Nutrition Facts label is found on the side or back of packages, a 
location that makes comparisons among multiple product alternatives difficult 
and time consuming. In addition, there can be more than fifty pieces of 
specific information available in the Nutrition Facts label. While the relatively 
comprehensive nature of the information disclosed is a benefit to certain con-
sumer segments, it makes the acquisition, integration, and comparisons 
across products more time consuming and burdensome for the harried con-
sumer. Many contend that the Nutrition Facts label is too complex and is 
more difficult than it need be for consumers to access the most critical 
nutrition information to evaluate product alternative healthfulness (Viswa-
nathan & Hastak, 2002). There are also many cues offered on the package by 
food manufacturers to signal nutritional benefits that are much easier to access 
and in turn may be used to draw inferences about the perceived healthfulness 
of products. Unfortunately, these inferences may or may not be consistent 
with the objective healthfulness of the product (Andrews, Burton, & Kees, 
2011; Kozup, Creyer, & Burton, 2003). 
Such acquisition, integration and processing issues are important as the 
FDA is considering modifications to the communication of nutrition infor-
mation that will increase the ease, or fluency, with which it may be accessed 
and potentially incorporated into consumer food judgments and decisions. 
These methods include the provision of front-of-package labeling and revision 
of the Nutrition Facts label (Federal Register, 2010b). 
Front-of-Package Nutrition Disclosures 
Over the past decade, consumers have encountered a plethora of front-of-
package (FOP) nutrition labeling systems and icons, including Grocery Manu-
facturers of America and the Food Marketing Institute's Facts-Up-Front 
system, the United Kingdom's traffic light system, and Hannaford's Guiding 
Stars (Andrews eta!., 2014; Federal Register, 2010b). As shown in Figure 20.3, 
generally, the systems can be divided into two broad types of disclosure systems: 
(1) evaluative or interpretive systems for the product that help with the evalu-
ation task, and (2) nutrient-specific or reductive FOP systems that reduce and 
transfer important calorie and nutrient information from a nutritional 
panel from the back or side of the package. The evaluative/interpretive system 
can be further subdivided into systems that provide consumers either with an 
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Figure 20.3 Examples of Dijjerent Types of Front-ofpackage Nutrition Systems. 
overall evaluation of a product's healthfulness and systems that offer an 
evaluation of specific nutrients (e.g., saturated fat and sodium). Examples 
of the former include the NuVal nutrition scoring system (a 1-100 scale) or 
the Institute of Medicine's recommended format (products receive 0-3 stars). 
The latter includes the United Kingdom's traffic light system, which color-codes 
(red, amber, green) the disclosure for specific nutrients. The evaluative/inter-
pretive systems usually require that the evaluation of the product or nutrient 
meets certain predetermined nutritional criteria to attain its score. In contrast, 
the nutrient-specific, reductive systems do not require any such additional 
evaluative criteria that must be determined. These systems have become popu-
lar with many manufacturers and trade groups and include the Facts-Up-Front 
icon and others using a Guideline Daily Amount (GDA)-type format. 
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In the past decade, an increasing amount of academic research has 
examined FOP labeling. While a complete review of this FOP literature 
is beyond the scope of this chapter (interested readers should see Andrews 
et al., 2014, and Hersey et al., 2013), some recent findings are consistent 
with the model offered in Figure 20.1. There is some evidence that FOP 
systems can increase attention to nutrition information and that there is 
some difference in the ease of processing information from different FOP 
nutrition disclosure systems (Hersey et al., 2013). For example, in a UK 
study it was found that a multiple traffic light format took the least time 
to interpret (the average time was 5.1 seconds) followed closely by the 
colored GDA (an average time of 5.4 seconds). The color-coding provided 
through quantitative scoring seems to aid attention and reduce the subse-
quent time for processing (Synovate, 2005; Hersey et al., 2013). Similarly, 
evaluative disclosures (e.g., traffic lights, number of stars, or 1-100 rating) 
seem to be perceived as requiring less time than GDA formats (Hersey et al., 
2013). However, other research that compared a colored traffic light-style 
nutrient-specific disclosure to a no-color option found no differences 
between the evaluative/interpretive format (i.e., traffic lights) and the reduc-
tive format (i.e., no color) in self-reported attention paid to the disclosure 
or how easily consumers could judge the product's healthfulness (Kees, 
Stafford, & Cho, 2014). 
It seems that consumers do like the general concept of some form of FOP 
labeling, and there are fairly consistent findings in the literature that consumers 
exposed to FOP labels perform better in understanding and identification 
of more healthful products than those exposed to no-FOP control conditions. 
Some studies have found that the use of evaluative formats with nutrient-
specific traffic light formats is associated with a higher likelihood of identifying 
the healthier food choices compared to labels presenting non-evaluative 
GDA information (Hersey et al., 2013; Newman, Howlett, & Burton, 2014). 
However, a comprehensive Institute of Medicine report concluded that no 
FOP nutrition information system is superior to all others and that each has 
strengths and weaknesses (10M, 2011). 
Current and Future Research Needs on FOP Labeling 
Despite an array of studies, there are substantial opportunities for future 
research to determine whether there is one specific FOP alternative that can 
most effectively serve needs across diverse situations, goal states, and consumer 
segments. In the model presented in Figure 20.1, we offer a brief overview of 
key variables of interest for FOP nutrition labeling: attention and acquisition 
of the information, processing and comprehension across individual differences 
and goals of various consumer segments, and broad effects and outcomes 
related to consumers' well-being (Andrews et al., 2014). 
Research examining how contextual variables in a store/shopping environ-
ment are related to FOP attention, acquisition, and use is clearly needed. 
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Perceptually, what precise design elements, including color, location, size, and 
contrast, enhance initial awareness and acquisition of the information 
(Andrews eta!., 2014)? How do different FOP label alternatives perform given 
variance in the number and positioning of manufacturer's nutrition claims, 
other promotion material, and level of package clutter? 
There is also a dire need to examine what is occurring with shoppers at 
the store level. Clearly, while academic researchers have difficulty integrating 
controlled designs with the retail shopping experience, there is a dearth of 
studies involving consumer responses at the retail shelf. The need for policy-
based decisions is obvious. For example, when consumers select a product at 
the store, observing their search behavior and choices and examining the role 
played by FOP information relative to other critical marketing variables 
are needed. 
More controlled experiments may expand our understanding of hybrid 
systems. While evaluative systems may help in comprehension and judgments 
(Hersey et a!., 2013; Newman, Howlett & Burton, 2014), they may at times 
create some bias depending on the specific objective nutrition profile and cutoff 
levels established (Andrews, Burton, & Kees, 2011; Andrews et a!., 2014). 
Is there a hybrid system that, despite some additional complexity due to the 
expanded information conveyed, maximizes benefits while minimizing weak-
nesses of a single system? 
Many questions that are critical to both policy and researchers relate to 
the long-term and broader effects of FOP labeling. To our knowledge, there 
is little research related to unintended consequences. For example, if an evalu-
ative disclosure reveals a superior "three-star" product or traffic light format 
dominated by green, does this stimulate overconsumption by granting the 
license to consume (e.g., Wansink & Chandan, 2006)? While there is some 
evidence that the use of FOP labels by a retailer may positively affect healthful 
choices (Dzhogleva & Inman, 2013; Hersey et a!., 2013), effects generally 
appear fairly small and are not always observed. Are there stronger behavioral 
effects of some FOP nutrition disclosure systems relative to others? Lastly, 
from a consumer health and welfare perspective, many researchers believe that 
the influence of mandates for labeling systems on new product development 
and reformulation will exceed effects on individual consumer behavior. If a 
standardized FOP system became required, how would it impact changes in the 
nutritional content of packaged foods, and would the more aggressive evalu-
ative systems (traffic light, 10M stars) motivate the most substantial product 
modifications? 
However, the questions and problems associated with obesity and the acqui-
sition, use, and processing of nutrition information also concern perceived 
limitations of the Nutrition Facts label mandated in the United States. The 
FDA has already proposed changes to the Nutrition Facts label and research 
addressing these initial proposals, and the breadth of effects when implemented 
will also be an emerging research concern, with possible implications for 
consumer well-being (Federal Register, 2014). 
Government Efforts to Aid Consumer Well-being: Understanding Federal Health Warnings and Disclosures 547 
Proposed Regulatory Action Regarding Changes 
to the Nutrition Facts Label 
In March 2014, the FDA requested comments on a number of proposed 
modifications to the Nutrition Facts label, including the enhancement of calorie 
information and adjustment of some of the serving size information (Federal 
Register, 2014). These changes represent the most substantial modifications 
since the introduction of the Nutrition Facts label twenty years ago. The impetus 
of this substantial proposed update to the Nutrition Facts disclosure on packaged 
foods is "to reflect the latest scientific information, including the link between 
diet and chronic diseases such as obesity and heart disease" (FDA, 2014b). 
There are a number of important format changes between the current and 
proposed Nutrition Facts label that can be observed in Figure 20.3. This 
includes greater emphasis on the calorie content and servings per container 
by increasing the type size and placing the information in bold type. Clearly, 
the changes in prominence are designed to encourage attention, allow easier 
access, and spur its use in forming health-related judgments about products. 
Furthermore, there are proposed changes to serving sizes listed to reflect more 
accurately amounts people currently eat, relative to their dietary habits in the 
1990s. Modifications proposed also include the presentation of calorie and 
nutrition information for the entire package of certain food products that could 
be consumed in a single sitting, including dual-column formats for both per 
serving and the entire package (Federal Register, 2014). Also, the modifications 
include switching the Daily Values (DVs) from the far-right to the far-left. 
While these are among the most prominent changes, the proposed rule lists 
some thirteen specific changes to the Nutrition Facts label, many of which can 
be directly observed in Figure 20.4. The FDA proposes that manufacturers 
have some two years after the effective date to comply with the final ruling. 
Future Research Needs 
Substantial research exists concerning the Nutrition Facts label that has exam-
ined alternative formats, effects on processing, evaluations of healthfulness 
and consumer choices, and macro-level influences of its implementation (see 
Drichoutis, Lazaridis, & Nayga, 2006, and Heike & Taylor, 2012, for compre-
hensive reviews). However, scant research has addressed these very specific 
changes proposed by the FDA and the White House (Harris, 2012). At this 
point, the FDA offers little direct evidence for effects, simply noting that it will 
"perform consumer research during this rulemaking process to evaluate 
how variations in label format may affect consumer understanding and use of 
the Nutrition Facts label" (Federal Register, 2014, p. 11882). 
These modifications for the Nutrition Facts label offer an excellent 
example of how the consumer research community can provide assistance to 
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Nutrition Facts Nutrition Facts 
Serving Size 2/3 cup (55g) 
Servings Per Container About 8 8 Servings per COntainer 
Amount Per Serving 
Calories 230 Calories from Fat 72 
% Dally Value* 
_, __ , ______ ~-~-~~--~-~~-,--~---------~-------
Total Fat 8g 12% 
Saturated Fat 
Trans Fat Og 
. ·-- -· -----~----~--
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Sodium 160mg 
Total Carbohydrate 37g 
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·Percent Daily Values are based on a 2,000 calorie diet 
Your daily value may be higher or lower depending on 
your calorie needs. 
Calories: 2,000 2,500 
Total Fat Less than 65g BOg 
Sat Fat Less than 20g 25g 
Cholesterol Less than 300mg 300mg 
Sodium Less than 2,400mg 2,400mg 
Total Carbohydrate 300g 37Sg 
Dietary Fiber 25g 30g 
Serving size 2/3 cup (55g) 
Amount per 213 cup 
Calories 230 
45% ·Iron 8mg 
5"'/o Potassium 235 mg 
• Footnote on Daily Values (DV) and calories 
reference to be inserted here. 
Figure 20.4. Current Nutrition Facts Panel Compared to the Proposed 
2014 Panel. 
Note: The proposed Nutrition Facts labels are available at www.fda.gov/Food/ 
GuidanceRegulation/GuidanceDocumentsRegulatorylnformation/LabelingNutrition/ 
ucm385663.htm#images. 
policy-related decisions that appear in dire need of conceptually based empirical 
research. Over the next three to five years, there is substantial opportunity 
for research examining how each of the specific modifications (as compared to 
the current "control" Nutrition Facts label and other possible alternatives) may 
affect attention, processing, and integration into nutrient and product evalu-
ations and influence choices among alternative choice sets. Which of the specific 
changes appear to have the greatest relative effects on product choices and 
evaluations? Subsequently, when the proposed changes are implemented in the 
future, what will be consumer reactions and effects in the marketplace? Will 
effects vary across individual difference variables (e.g., those low in nutrition 
consciousness and objective nutrition knowledge) and consumer segments at 
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greater risk (e.g., high body mass index [BMI], low literacy, those suffering 
from diabetes or heart disease)? How do the changes to the Nutrition Facts 
label interact with alternative FOP labeling? 
While revisions to both the Nutrition Facts label and front of the package 
may be beneficial to consumers' well-being, it may be argued that the infor-
mation required to make an informed food choice is already available in 
the Nutrition Facts label for knowledgeable and motivated consumers (if the 
effort is expended to obtain it). However, for food consumed outside of 
the home, information has not been disclosed to consumers at the point 
of purchase, and changes to consumer lifestyles have made this an increasingly 
important issue. 
The NLEA (1990) exempted restaurants and other venues selling 
ready-to-consume prepared foods from nutrition labeling. However, U.S. 
consumers now consume some one-third of their total calories and spend 
almost one-half of their food budget on foods prepared outside the home, 
percentages that have grown substantially over the past forty years (Federal 
Register, 2011). Given these statistics and rising levels of obesity, Section 
4205 of the U.S. Patient Protection and Affordable Care Act (2010) required 
chain restaurants with twenty or more outlets in the United States to provide 
nutrient content information for standard menu items. Given divergent label-
ing requirements for menu disclosures from an increasing number of states and 
localities, many major restaurant chains and the National Restaurant Associ-
ation supported national legislation that would standardize labeling require-
ments. The FDA was charged with establishing the final rules, regulations, and 
outlets to be covered by the legislation, and the labeling changes are scheduled 
to occur in 2015 and 2016. Among the many difficulties encountered by the 
FDA were which retail establishments to include. The legislation called for 
calorie labeling for vending machines, restaurants, and "similar retail food 
establishments," yet determining what types of establishments should and 
should not be included as "similar" proved extremely problematic. Conveni-
ence stores, supermarkets, and take-out-only pizza chains lobbied for exemp-
tions from the requirements. The final ruling included all of these outlets, but 
there are still on-going appeals. 
Current Findings and Future Research Needs 
Because a number of states and local governments have mandated calorie 
labeling for restaurant chains in the past seven years, several field- and lab-
based experimental studies have been conducted. In a recent review that exam-
ined studies published between 2007 and 2013, it was concluded that despite 
some positive results concerning effectiveness in lab experiments (e.g., Burton, 
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Howlett, & Tangari, 2009), the market-based field studies suggest that calorie 
labeling generally will not reduce the total calories ordered across the general 
population (Kiszko, Martinez, Abrams, & Elbel, 2014). When considering 
the underlying model of when disclosures are likely to have effects, such 
macro-level findings should come as little surprise (Burton & Kees, 2012). That 
is, the conditions under which effects on a specific consumers' purchase appear 
relatively narrow; it is far more likely to find segments in which the labeling 
may have no effect, or even increase calories in an order, than the opposite. 
For example, as suggested in our model, there is a hierarchical chain of very 
specific conditions, including attention and awareness, processing conditions, 
integration and evaluation, and situational and individual difference variables 
that need to be satisfied for consumers to be likely to reduce the caloric content 
for any specific order at a restaurant (Burton & Kees, 2012). As with any 
warning or disclosure, restaurant patrons must be aware of the disclosed 
calorie information. However, information acquisition in many menu board 
or drive-thru venues, when coupled with time constraints, may be fairly diffi-
cult. If consumers tend to order certain familiar items habitually, they may not 
even examine a menu board or menu. If found and considered, consumers must 
have the motivation and knowledge to process and incorporate the calorie 
information into judgments and choices. For the majority of consumers, food 
attributes such as taste, price, convenience, and meal size are more diagnostic 
and influential for decisions than is product healthfulness, and both percep-
tually and objectively these attributes may be negatively correlated to calorie 
levels. In fact, some may contend that the restaurant industry's success in 
designing and delivering convenient, reasonably priced, tasty fare has led to 
the tremendous increase in the food dollar captured and helped make calories 
and nutrition a tertiary concern for most consumers. It is also argued that for 
calorie labeling to have a favorable influence, the disclosed information must 
deviate from consumers' prior expectations (Burton, Creyer, Kees, & Huggins, 
2006; Howlett, Burton, Bates, & Huggins, 2009). If calorie information merely 
confirms prior expectations, then little change in choice behavior is anticipated. 
In addition, there are situational influences in any restaurant setting and 
biases in processing that may reduce the likelihood of calorie labeling having 
a substantial influence (Burton & Kees, 2012; Chandan & Wansink, 2007). 
Of course, there are also differences in calorie needs and wants that affect 
choices. For instance, twenty-year-old construction workers or high school 
athletes visiting a fast food restaurant for lunch may see a low calorie meal as 
insufficient for their specific dietary needs. They may use labeling to help 
identify a set of high calorie items required, given their daily activity level and 
caloric expenditure. Given the variety of motivations for food consumption 
(maximization of taste, value, convenience, emotional comfort), there are 
many segments of consumers for which calorie labeling is very unlikely to have 
intended effects. 
Future research can consider the very refined, select segment of consumers 
who may be impacted by in-restaurant calorie labeling. The conceptualization 
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regarding when and how disclosures are effective suggest possible four-way or 
higher interactions (e.g., calorie expectations x motivation x situation (time 
pressure, social) x disclosure) that may be considered. Calorie labeling is likely 
to positively affect the few rather than the many, and this presents intriguing 
research possibilities that can be explored. 
Related to the preceding, situational variables such as the presentation 
of items and calories, the relationship of nutritional content to other critical 
evaluation attributes (price, perceived taste, size), and time pressure may all be 
interrelated in their effects (Parker & Lehmann, 2014). While the legislation 
requires that calorie labeling be used for chain restaurants and vending 
machines, at this point it appears it will also include a broader set of retailers, 
such as prepared food at grocery stores, convenience stores, take-out-only 
chains, and such. However, how the aspects of the legislation affect very 
different venues, such as buffets, fast food chains, casual dining table service 
restaurants, vending machines, and other venues covered will be of interest to 
numerous constituencies. 
Also, as noted previously, one may consider across each type of venue 
the nature of the target market. Because goals and motives vary, interest in 
the nature of effects for the segment of twenty-year-old athletes relative to the 
segment of sedentary, overweight forty-five-to-sixty-five-year-old consumers 
suffering from heart disease will differ dramatically. Studies that have 
shown some increase in general calorie consumption probably mask significant 
differences for very refined segments. As with FOP labeling, how the required 
disclosures affect the modification and new product offerings of restaurant 
chains is of substantial interest. 
In sum, while most of the market-based studies have focused on broad calorie 
consumption effects for the restaurant patron population (Kiszko eta!., 2014), 
when the law is finally implemented, research should consider higher-order 
moderating effects (Burton & Kees, 2012) and longer-term consequences 
for consumers and firms. 
While we view tobacco and food as areas in which disclosures and 
warnings can have a broad impact on population well-being, there are 
other very important domains in which disclosures and warnings can have an 
important impact. One such area is consumer finance. Financial disclosures 
(e.g., mandatory mortgage loan disclosures, credit card disclosures, financial 
privacy notices) are a fundamental component of consumer protection policy 
for financial services (Durkin & Elliehausen, 2011). While financial disclosures 
are intended to provide consumers with basic information and facilitate com-
parisons among alternatives, sometimes there are unintended consequences 
(Navarro-Martinez et a!., 2011 ). For instance, some research has documented 
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that these disclosures can overwhelm consumers with information presented 
in complex formats, which only further confuses consumers (Lacko & 
Pappalardo, 2010; Woodward & Hall, 2010). Research is needed to better 
understand how to develop financial disclosures that consumers pay attention 
to, understand, and use in their decision making (Garrison, 2012). Indeed, 
the literature lacks conclusive evidence on how financial disclosures impact 
decisions and outcomes, especially in light of contextual, market, and individual 
difference factors (e.g., financial literacy) outlined in Figure 20.1 (Blumenthal & 
Perry, 2012). 
Another domain in which disclosures can have a significant impact 
on consumer decisions and well-being is direct-to-consumer advertising 
(DTCA) of prescription drugs. When drug companies market directly to 
consumers, the FDA requires that the marketer balance information about 
how the drug can help treat certain conditions with a mandatory risk disclos-
ure (i.e., fair balance; Aikin, O'Donoghue, Swasy, & Sullivan, 2001). While 
DTCA risk disclosures are predicated on the assumption that consumers 
appropriately interpret this information to make informed decisions (FDA, 
2009a), similar to financial disclosures discussed previously, research has 
found that risk disclosures in DTCA are often ignored (Menon, Deshpandi, 
Perri, & Zinkhan, 2003), can lead to overestimation of product risk (Cox, 
20 I 0), and can adversely affect product use compliance (Wosinka, 2005). 
Similar to the other domains discussed in this chapter, and consistent with 
Figure 20.1, DTCA risk disclosures can be impacted by emotions (Cox, Cox, 
& Mantel, 2010), individual differences (Ahn, Park, & Haley, 2014), back-
ground noise and clutter (Andrews, 2011), and expert (physician) advice 
(Frosch & Grande, 2010). 
The final topic that will be addressed in the chapter deals with the array 
of disclosures, disclaimers, and qualifiers that are required for food and 
supplement claims. For instance, some foods that make nutrient content 
claims (e.g., "low fat") are also required to carry a disclosure statement when 
that same food contains exceedingly high levels of another nutrient (e.g., "See 
nutrition information for sodium content"). For supplements, qualified health 
claims may make a statement that a product reduces the risk of a particular 
condition (i.e., coronary heart disease), but are also required to present a 
scientific certainty qualifier that the evidence behind the claim is preliminary, 
uncertain, or even unlikely to support the claim. 
This domain is an excellent example of the difficulty of designing effective 
disclosures and warnings to communicate potential product risks without vio-
lating the rights of the marketer to communicate the benefits of its products. 
While there have been numerous studies to help inform the design of such 
food and supplement disclosures (Mason, Scammon, & Fang, 2007), federal 
agencies continue to struggle to develop effective disclosures. For instance, the 
FTC concluded that qualified health claims are not interpreted by consumers 
as intended (FTC, 2006). Much of the extant research suggests that the food 
and supplement disclaimer/disclosure environment is confusing to consumers 
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(Hasler, 2008) and sometimes can even result in the opposite of the desired 
effect (FDA, 2009b). As in the previously mentioned domains, and consistent 
with Figure 20.1, consumer research is critical in ensuring consumers pay 
attention to, process, and make appropriate decisions based on the information 
disclosures. 
Across the different domains discussed in this chapter, it is clear 
that warnings and disclosures are an important regulatory tool for policy 
makers to impact consumer health and well-being. Federal laws and regulations 
mandate warnings and disclosures on product packaging, at the point of 
purchase, and/or in advertising to protect consumers from potentially danger-
ous products. For some issues, there appears to be strong empirical support for 
a specific direction that would result in positive consumer and social outcomes 
(e.g., stronger cigarette warning labels in the United States). However, for most 
issues reviewed in this chapter, more research is needed to understand the 
optimum design of warnings and disclosures to facilitate consumer understand-
ing and minimize unintended consequences. 
The Model of Consumer Responses to Warnings and Disclosures offered 
in Figure 20.1 draws from a rich literature of consumer information processing 
(e.g., McGuire, 1980; Petty and Cacioppo, 1986; Rogers, 1975; Wogalter, 2006) 
to offer some of the key outcome variables, mediators, and moderators to 
consider when conducting warnings and disclosures research. These variables 
are important for researchers to consider given that developing effective warn-
ings and disclosures requires a clear understanding of how consumers acquire, 
process, and use the information to shape their decisions. Particular attention 
should be paid to the potential moderating variables in the model. Consistent 
with marketing theory, any potential outcomes from exposure to a warning 
or disclosure will vary based on individual differences, situational factors, and 
consumer goals. 
A considerable number of research questions are offered in this chapter, and 
we present an overview of some of these questions and issues in Table 20.1. 
Of course, for each of these questions there are potential moderating and 
mediating influences that may be considered and are of interest to consumers' 
well-being. Other questions could address effects across the various stages in 
our proposed model. While regulatory agencies are charged with crafting 
laws and rules to guide warning and disclosure policy, these agencies are 
limited in the research they are able to conduct. Thus, we hope this chapter 
encourages research from the academic community, which is critical to ensure 
that warning and disclosure regulation is grounded in well-designed empirical 
studies. Rigorous research using appropriate methodologies and relevant 
samples is important to ensure that warnings and disclosures have the greatest 
possible positive impact on consumer well-being. 
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Table 20.1 Overview of Some Current Warning and Disclosure Issues and Examples of 
Possible Research Questions. 
Warning and Disclosure 
Challenges 
Graphic Health Warnings 
on Packages and in 
Advertising 




Front of Package Nutrition 
Disclosures 
Modifications to the Nutri-
tion Facts Disclosure 
Calorie Labeling in Chain 
Restaurants and Other 
Away-from-Home Venues 
Possible Research Question Recommendation 
What types of warnings are most effective for persuading 
adolescent smokers and nonsmokers? 
Can the effects of graphic health warnings persist over time or 
are they prone to "wear out"? 
How effective are graphic health warnings at influencing actual 
long-term smoking behavior? 
What are the trade-offs between effects of warnings on risks and 
use for MRTPs for adolescents and young non-users, relative to 
effects on smokers who may be attempting to curtail or eliminate 
cigarette consumption? 
How do consumers process "harm reduction" disclosures for 
MRTPs (e.g., will consumers understand these products to 
be "reduced" risk relative to combustible cigarettes or will they 
perceive them as completely "safe")? 
What are the beliefs about risks associated with e-cigarettes 
compared to the objective research, and how would various 
warnings affect risk perceptions and usage? 
Can disclosures communicate the potential lower risk of 
e-cigarettes without the unintended consequence of attracting 
new or "dual use" tobacco users? 
Is there one specific FOP alternative that would most effectively 
aid consumers in identifying the most healthful product in a 
choice set? Does this FOP affect choice and consumption levels 
of segments differing in motivation and knowledge, goal states, 
and BMis? 
Is there a hybrid system that maximizes benefits while minimizing 
weaknesses of a single evaluative or reductive system? 
Would a mandated system have an effect on product 
reformulations and new (more healthful) products, and is there a 
specific FOP alternative that would lead to the greatest level of 
more healthful reformulations? 
How do the combined and the individual recommended changes 
affect product perceptions and choices, relative to the current 
label? Which one change has the most substantial effect? Will 
consumers notice and act upon the inclusion of added sugars? 
Does moving the daily values (DVs) to the left of the label affect 
the accuracy of processing nutrients for those expecting them to 
be on the right? 
Do increases (decreases) in the serving size for specific products 
affect consumption levels? 
How does labeling affect choices and levels of consumption 
across item type, calorie expectations, consumer goals and 
motivation, situation, and consumer risk level? 
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Table 20.1 (cont.) 
Warning and Disclosure 
Challenges 
Miscellaneous Applications 
for Warnings and 
Disclosures 
Possible Research Question Recommendation 
How can the information be organized and presented in a 
manner that maximizes intended and minimizes unintended 
consequences? 
What are the different effects of labeling across different venues 
(fast food vs. dinner house chains, vending machines, and 
potentially convenience stores, grocery stores, and others 
that may be included)? 
How can disclosures for complex products (e.g., financial 
products, long list of harmful tobacco ingredients) be revised to 
communicate critical information without overwhelming and/or 
confusing consumers? 
What warning and/or disclosure formats are optimal for 
communicating risk for products that are extremely beneficial 
for some consumers (e.g., prescription drugs) without 
"overwarning"? 
Can disclosures be effective at informing consumers about 
products for which the scientific evidence is uncertain about the 
consumer benefits of the product (e.g., food/nutritional 
supplements)? 
As a final note for academics with a strong interest conducting research 
that impacts public policy and federal regulation, there are opportunities to 
partner with government agencies. Many agencies within the FDA such as 
the Center for Food Safety and Applied Nutrition (CFSAN) and the Center 
for Tobacco Products (CTP) are understaffed with researchers to address the 
issues that are raised in this chapter (among many others that are important 
for consumer welfare). These agencies regularly bring in academics for semester 
or year-long appointments as Special Government Employees. For those who 
are unable to commit to a semester or longer, there are various important 
government committees that welcome academic members (e.g., the FDA Risk 
Communication Advisory Committee and the White House's Social and 
Behavioral Science Team). In our experience, agency officials welcome the 
help from the academic community in researching and understanding these 
very important policy issues. 
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